DZ2649A1 - Association des principes actifs pour le traitement de la démence sénile du type alzheimer. - Google Patents

Association des principes actifs pour le traitement de la démence sénile du type alzheimer.

Info

Publication number
DZ2649A1
DZ2649A1 DZ980259A DZ980259A DZ2649A1 DZ 2649 A1 DZ2649 A1 DZ 2649A1 DZ 980259 A DZ980259 A DZ 980259A DZ 980259 A DZ980259 A DZ 980259A DZ 2649 A1 DZ2649 A1 DZ 2649A1
Authority
DZ
Algeria
Prior art keywords
association
treatment
senile dementia
active principles
alzheimer type
Prior art date
Application number
DZ980259A
Other languages
English (en)
Inventor
Jean-Pierre Maffrand
Philippe Soubrie
Jean-Paul Terranova
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9714322A external-priority patent/FR2771007B1/fr
Priority claimed from FR9714324A external-priority patent/FR2771006B1/fr
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of DZ2649A1 publication Critical patent/DZ2649A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DZ980259A 1997-11-14 1998-11-11 Association des principes actifs pour le traitement de la démence sénile du type alzheimer. DZ2649A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714322A FR2771007B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer
FR9714324A FR2771006B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer

Publications (1)

Publication Number Publication Date
DZ2649A1 true DZ2649A1 (fr) 2004-12-28

Family

ID=26233932

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980259A DZ2649A1 (fr) 1997-11-14 1998-11-11 Association des principes actifs pour le traitement de la démence sénile du type alzheimer.

Country Status (27)

Country Link
EP (1) EP1030671A1 (fr)
JP (1) JP2001523642A (fr)
KR (1) KR100599350B1 (fr)
CN (1) CN1243540C (fr)
AU (1) AU743228B2 (fr)
BG (1) BG64819B1 (fr)
BR (1) BR9814035A (fr)
CA (1) CA2309966A1 (fr)
CO (1) CO4980891A1 (fr)
DZ (1) DZ2649A1 (fr)
EA (1) EA003255B1 (fr)
EE (1) EE04235B1 (fr)
HU (1) HUP0100098A3 (fr)
ID (1) ID24933A (fr)
IL (2) IL136122A0 (fr)
IS (1) IS5482A (fr)
MY (1) MY120461A (fr)
NO (1) NO20002450L (fr)
NZ (1) NZ504420A (fr)
OA (1) OA11464A (fr)
PL (1) PL194597B1 (fr)
SA (1) SA98190747B1 (fr)
SK (1) SK286040B6 (fr)
TR (1) TR200001262T2 (fr)
TW (1) TW585766B (fr)
UY (1) UY25247A1 (fr)
WO (1) WO1999025363A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2389937T1 (sl) 2002-06-14 2018-10-30 Toyama Chemical Co., Ltd, Farmacevtska sestava za izboljšanje možganske funkcije
CN1681941A (zh) * 2002-08-07 2005-10-12 诺瓦提斯公司 基于ApoE基因型治疗痴呆的方法
CN1520818A (zh) * 2003-02-09 2004-08-18 山东绿叶天然药物研究开发有限公司 治疗老年性痴呆的胆碱酯酶抑制剂药物组合物
JP2008525313A (ja) 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬の安定化方法
EP4023294A1 (fr) 2014-01-31 2022-07-06 Cognition Therapeutics, Inc. Compositions contenant une isoindoline et méthodes de traitement de la maladie d'alzheimer
BR112019023851A2 (pt) 2017-05-15 2020-08-18 Cognition Therapeutics, Inc. compostos, suas composições farmacêuticas e métodos para tratamento de doenças neurodegenerativas
WO2019182319A1 (fr) * 2018-03-20 2019-09-26 (주)인벤티지랩 Procédé de préparation de composition pharmaceutique de prévention ou de traitement de maladies associées au trouble cognitif, et composition pharmaceutique de prévention ou de traitement de maladies associées au trouble cognitif, préparée par le procédé de préparation
KR102224918B1 (ko) 2018-03-20 2021-03-09 (주)인벤티지랩 도네페질 및 메만틴을 포함하는 인지 장애 관련 질병의 예방 또는 치료용 약학적 복합 조성물 및 이의 제조 방법
CN109265391B (zh) * 2018-11-13 2021-11-19 枣庄学院 联苯多取代1,2,5,6-四氢吡啶化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5453428A (en) * 1991-02-14 1995-09-26 The Mount Sinai School Of Medicine Of The City Of New York Method and composition for the treatment of apathy-amotivation syndrome
CN1126546C (zh) * 1995-03-06 2003-11-05 英特纽隆制剂药有限公司 使用胞磷胆碱减少梗塞面积
FR2736053B1 (fr) * 1995-06-28 1997-09-19 Sanofi Sa Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines

Also Published As

Publication number Publication date
UY25247A1 (es) 2001-05-31
CA2309966A1 (fr) 1999-05-27
BR9814035A (pt) 2000-09-26
IS5482A (is) 2000-05-09
CO4980891A1 (es) 2000-11-27
HUP0100098A3 (en) 2001-12-28
TW585766B (en) 2004-05-01
EP1030671A1 (fr) 2000-08-30
KR20010032099A (ko) 2001-04-16
HUP0100098A2 (hu) 2001-07-30
BG64819B1 (bg) 2006-05-31
CN1285742A (zh) 2001-02-28
KR100599350B1 (ko) 2006-07-12
AU1160999A (en) 1999-06-07
IL136122A0 (en) 2001-05-20
WO1999025363A1 (fr) 1999-05-27
SK7112000A3 (en) 2000-10-09
ID24933A (id) 2000-08-31
AU743228B2 (en) 2002-01-24
SA98190747B1 (ar) 2006-11-04
PL340500A1 (en) 2001-02-12
OA11464A (en) 2003-11-18
JP2001523642A (ja) 2001-11-27
NZ504420A (en) 2003-08-29
EE200000290A (et) 2001-06-15
TR200001262T2 (tr) 2001-01-22
IL136122A (en) 2006-07-05
EE04235B1 (et) 2004-02-16
NO20002450L (no) 2000-07-14
CN1243540C (zh) 2006-03-01
MY120461A (en) 2005-10-31
NO20002450D0 (no) 2000-05-11
BG104428A (en) 2001-08-31
SK286040B6 (sk) 2008-01-07
EA200000412A1 (ru) 2000-12-25
EA003255B1 (ru) 2003-02-27
PL194597B1 (pl) 2007-06-29

Similar Documents

Publication Publication Date Title
FR07C0046I2 (fr) Beta-l-2'-desoxy-nucleosides pour le traitement de l'hepatite b
ATE279407T1 (de) Fsh mimetika zur behandlung von infertilität
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
FR2718351B1 (fr) Procédé pour la déformation permanente des matières kératiniques.
FR2721823B1 (fr) Procede pour la deformation permanente des matieres keratiniques
DZ2649A1 (fr) Association des principes actifs pour le traitement de la démence sénile du type alzheimer.
FR2705966B1 (fr) Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
DE69607728D1 (de) Thixogussverfahren
MA22649A1 (fr) Procede de preparation de composes pour le traitement des maladies en rapport avec le leucotriene .
PH31643A (en) 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease.
FR2684546B3 (fr) Instrument de traitement, en particulier pour le traitement cosmetique du visage.
DZ2012A1 (fr) Benzamides pour le traitement de dégénérescences neurologiques.
MA25852A1 (fr) Methode pour le traitement de l'inflammation.
FR2719240B1 (fr) Procédé de traitement des suspensions huileuses.
FR2800614B1 (fr) Composition pour le traitement des infections des voies respiratoires
FR2771007B1 (fr) Association de principes actifs pour le traitement de la demence senile du type alzheimer
FR2771006B1 (fr) Association de principes actifs pour le traitement de la demence senile du type alzheimer
DE60201440D1 (de) Aryl-8-azabicyclo[3.2.1]octanes für die behandlung von depression
FR2713657B1 (fr) Nouveaux vecteurs pour le traitement du sida.
MA26908A1 (fr) S-methyl-dihydro-ziprasidone pour le traitement de troubles psychiatriques et oculaires
FR2680123B1 (fr) Procede de traitement de residus fortement polluants pour l'environnement.
FR2806293B1 (fr) Implants scleraux pour le traitement du decollement de retine
FR2694748B1 (fr) Décanteur-digesteur pour le traitement des eaux ménagères de rejet.
IT1281347B1 (it) Rodiggio autosterzante per rotabili su ferro
FR2706307B1 (fr) Formule pour traitement du sida.